Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Evaluation of Definitions for Oral Anticoagulant–Associated Major Bleeding: A Population-Based Cohort Study

Yan Xu, MD, Tara Gomes, PhD MHSc, Philip S. Wells, MDMSc,FRCP, Ana Johnson, PhD, Michelle Sholzberg, MD

Blood (2018) 132 (Supplement 1): 426.

https://doi.org/10.1182/blood-2018-99-111207

Published: 2018

Journal Articles

Bleeding and Thrombotic Risk in Low Dose Heparin Infusion As Compared to Standard Dose Heparin Infusion

Forat Lutfi, MD, Rohit Boshnoi, MD, Vikas Patel, MD, Aisha Alfasi, Michael Setteducato, Shuyao Zhang, Chintan Shah, MD, Saji Kurian, PharmD, Chethana Kamath, Dae Jun Kim, Martina C. Murphy, MD

Blood (2018) 132 (Supplement 1): 1251.

https://doi.org/10.1182/blood-2018-99-110232

Published: 2018

Journal Articles

The Impact of Adding Aspirin to Warfarin without an Apparent Indication: An Exploration of Patients Anticoagulated for Atrial Fibrillation or Venous Thromboembolic Disease

Jordan K. Schaefer, MD, Nicole M. Souphis, Suman L. Sood, MD MSCE, Brian Haymart, RN, MS, Xiaokui Gu, MA, Eva Kline-Rogers, RN, MS, Steven L. Almany, MD, Jay H. Kozlowski, MD, Gregory D. Krol, MD, Scott Kaatz, DO, MSc, James B. Froehlich, MD MPH, Geoffrey D. Barnes, MD MSc

Blood (2017) 130 (Supplement 1): 220.

https://doi.org/10.1182/blood.V130.Suppl_1.220.220

Published: 2017

Journal Articles

Data of Real-Life Anticoagulant Treatment in Patients Diagnosed with Nonvalvular Atrial Fibrillation and Secondary Prevention of Venous Thromboembolic Disease with Edoxaban: Experience in Our Center

Maria Almudena Garcia Ruiz, Marta Rivas Luque, Pablo Romero Garcia, MDCINE Resident, Manuel Jurado, MD PhD

Blood (2017) 130 (Supplement 1): 4920.

https://doi.org/10.1182/blood.V130.Suppl_1.4920.4920

Published: 2017

Journal Articles

Effectiveness and Safety of the 15 Mg Dose of Rivaroxaban Compared with Vitamin k Antagonists in Patients with Atrial Fibrillation: Results from a Cohort Study in the Nationwide French Claims and Hospitalization Database (SNIIRAM)

Laurent Fauchier, MD PhD, Patrick Blin, MD PhD, Frédéric Sacher, MD PhD, Caroline Dureau-Pournin, MSc, Marie-Agnes Bernard, MSc, Regis Lassalle, Cécile Droz-Perroteau, PhD, Jean Dallongeville, MD PhD, Nicholas Moore, MD PhD FRCP

Blood (2017) 130 (Supplement 1): 2390.

https://doi.org/10.1182/blood.V130.Suppl_1.2390.2390

Published: 2017

Journal Articles

Effectiveness and Safety of Rivaroxaban Vs. Warfarin in Patients with Nonvalvular Atrial Fibrillation and Moderate-to-Severe Chronic Kidney Disease

Craig I. Coleman, PharmD, Brandon K. Martinez, PharmD, Alexander G. G. Turpie, MD, Nitesh Sood, MD, Thomas J. Bunz, PharmD, PhD, Reinhold Kreutz, PhD

Blood (2017) 130 (Supplement 1): 2393.

https://doi.org/10.1182/blood.V130.Suppl_1.2393.2393

Published: 2017

Journal Articles

Prediction of Bleeding Risk in Patients on Extended Oral Anticoagulation for Venous Thromboembolism

Philip S Wells, MD, Michael J. Kovacs, MD FRCPC, David Anderson, MD, Susan R. Kahn, MD, Clive Kearon, MB, Sam Schulman, MD PhD FRCPC, David M. Keeling, MD, Scott Kaatz, DO, MSc, Susan Solymoss, MD, Daniel Corsi, PhD, Marc Rodger, MD MSc, FRCPC

Blood (2016) 128 (22): 139.

https://doi.org/10.1182/blood.V128.22.139.139

Published: 2016

Journal Articles

Are Direct Oral Anticoagulants Plasma Concentrations Associated with the Risk of Postoperative Bleeding? Results from the Real Life Cohort

Pável Olivera, MD, Vicente Cortina, Verónica Pons, MD, Tania Canals, MD, Erik Johansson, MD, Francesc Bosch, MD PhD, Amparo Santamaría, MD PhD

Blood (2016) 128 (22): 3819.

https://doi.org/10.1182/blood.V128.22.3819.3819

Published: 2016

Journal Articles

Pattern and Management of Intracranial Haemorrhage with Rivaroxaban or Dabigatran Compared to Vitamin K Antagonists - Results of the Prospective Dresden Noac Registry

Sandra Marten, MD, Luise Tittl, B.Sc., Katharina Daschkow, Jan Beyer-Westendorf, MD

Blood (2015) 126 (23): 1127.

https://doi.org/10.1182/blood.V126.23.1127.1127

Published: 2015

Journal Articles

Pattern and Management of ISTH Major Bleeding Complications with Direct Oral Anticoagulants - Results of the Prospective Dresden Noac Registry (NCT01588119)

Sandra Marten, MD, Luise Tittl, B.Sc., Katharina Daschkow, Jan Beyer-Westendorf, MD

Blood (2015) 126 (23): 892.

https://doi.org/10.1182/blood.V126.23.892.892

Published: 2015

Journal Articles

Early Comparison of Major Bleeding, Stroke and Associated Medical Costs Among Treatment-Naive Non-Valvular Atrial Fibrillation Patients Initiating Apixaban, Dabigatran, Rivaroxaban or Warfarin

Amin N Alpesh, MBA, MD, Allison Keshishian, MPH, Lin Xie, MA, MS, Onur Baser, MS, PhD, Kwanza Price, MPH, Lien Vo, MPH, PharmD, Prianka Singh, PharmD, Amanda Bruno, MPH, PhD, Jack Mardekian, PhD, Wilson Tan, MRCS, MD, Shalabh Singhal, MD, Chad Patel, PharmD, Kevin Odell, PharmD, Jeffrey Trocio, MPH

Blood (2015) 126 (23): 745.

https://doi.org/10.1182/blood.V126.23.745.745

Published: 2015

Journal Articles

Detecting Bleeding Risk in Patients Taking Vitamin K Antagonists Using Thrombin Generation Tests

Saartje Bloemen, Arina ten Cate-Hoek, Hugo ten Cate, Bas De Laat, PhD

Blood (2014) 124 (21): 2869.

https://doi.org/10.1182/blood.V124.21.2869.2869

Published: 2014

Journal Articles

Real Life Efficacy and Safety of Dabigatran for Stroke Prevention in Atrial Fibrillation – Final Results of the Prospective Noac Registry (NCT01588119)

Franziska Ebertz, Sebastian Werth, MD, Christina Köhler, MD, Franziska Michalski, Ulrike Hänsel, Luise Tittl, Katharina Daschkow, Thomas Schreier, Jan Beyer-Westendorf, MD

Blood (2014) 124 (21): 1541.

https://doi.org/10.1182/blood.V124.21.1541.1541

Published: 2014

Journal Articles

Inferior Vena Cava Filters: Outcomes In Patients With Active Cancer

Ana Isabel Casanegra, MD, RPVI, FSVM, Alfonso Tafur, MD, RPVI, Halima Suria, MD, Peter Mseti, MD

Blood (2013) 122 (21): 1148.

https://doi.org/10.1182/blood.V122.21.1148.1148

Published: 2013

Journal Articles

Clinical Performance of Bleeding Risk Scores for Predicting Major and Clinically Relevant Non-Major Bleeding Events in Patients Receiving Oral Anticoagulant Therapy

Sarag Burgess, BScPharm, Natalie Crown, PharmD, Martha L Louzada, BSc, MD, MSc, George Dresser, MD PhD, Richard Kim, MD, Alejandro Lazo-Langner, MD, MSc

Blood (2011) 118 (21): 2311.

https://doi.org/10.1182/blood.V118.21.2311.2311

Published: 2011

NARROW

Evaluation of Definitions for Oral Anticoagulant–Associated Major Bleeding: A Population-Based Cohort Study

Bleeding and Thrombotic Risk in Low Dose Heparin Infusion As Compared to Standard Dose Heparin Infusion

The Impact of Adding Aspirin to Warfarin without an Apparent Indication: An Exploration of Patients Anticoagulated for Atrial Fibrillation or Venous Thromboembolic Disease

Data of Real-Life Anticoagulant Treatment in Patients Diagnosed with Nonvalvular Atrial Fibrillation and Secondary Prevention of Venous Thromboembolic Disease with Edoxaban: Experience in Our Center

Effectiveness and Safety of the 15 Mg Dose of Rivaroxaban Compared with Vitamin k Antagonists in Patients with Atrial Fibrillation: Results from a Cohort Study in the Nationwide French Claims and Hospitalization Database (SNIIRAM)

Effectiveness and Safety of Rivaroxaban Vs. Warfarin in Patients with Nonvalvular Atrial Fibrillation and Moderate-to-Severe Chronic Kidney Disease

Prediction of Bleeding Risk in Patients on Extended Oral Anticoagulation for Venous Thromboembolism

Are Direct Oral Anticoagulants Plasma Concentrations Associated with the Risk of Postoperative Bleeding? Results from the Real Life Cohort

Pattern and Management of Intracranial Haemorrhage with Rivaroxaban or Dabigatran Compared to Vitamin K Antagonists - Results of the Prospective Dresden Noac Registry

Pattern and Management of ISTH Major Bleeding Complications with Direct Oral Anticoagulants - Results of the Prospective Dresden Noac Registry (NCT01588119)

Early Comparison of Major Bleeding, Stroke and Associated Medical Costs Among Treatment-Naive Non-Valvular Atrial Fibrillation Patients Initiating Apixaban, Dabigatran, Rivaroxaban or Warfarin

Detecting Bleeding Risk in Patients Taking Vitamin K Antagonists Using Thrombin Generation Tests

Real Life Efficacy and Safety of Dabigatran for Stroke Prevention in Atrial Fibrillation – Final Results of the Prospective Noac Registry (NCT01588119)

Inferior Vena Cava Filters: Outcomes In Patients With Active Cancer

Clinical Performance of Bleeding Risk Scores for Predicting Major and Clinically Relevant Non-Major Bleeding Events in Patients Receiving Oral Anticoagulant Therapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only